Access cutting-edge schizophrenia treatment through this clinical trial at a research site in Belmont. Study-provided care at no cost to qualified participants.
Access schizophrenia specialists in Belmont at no cost
This study follows strict safety protocols and ethical guidelines
All study-related schizophrenia treatment provided free
The goal of this double-blind, placebo-controlled randomized clinical trial is to test the effect of 12 weeks of orally administered MitoQ (mitoquinol mesylate) supplementation on cognition in 50 people with early phase schizophrenia-spectrum disorders (E-SSD) who have mitochondrial dysfunction (called high risk, or HR). Cognitive impairments in SSD can cause significant disability. Yet, there are no effective treatments for cognitive impairments in SSD. It has been shown that alterations in a c
Sponsor: Mclean Hospital
Check if you qualify for this schizophrenia clinical trial in Belmont, MA
If you're searching for schizophrenia treatment options in Belmont, MA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Belmont research site is actively enrolling participants for this clinical trial. You'll receive care from experienced schizophrenia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.